SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dwayne Hines who wrote (460)4/18/2009 1:25:58 PM
From: geewiz   of 534
 
Thanks for posting the article.

I got out of the company and threw my hopes on powderject. It's now been acquired. What caused many of us to loose faith in the management were all the false starts. The serious holders switched the on-line chatter to the YAHOO message board around the millenium.

There's new management; however the development loss carry-forwards and dilution of shareholder value have been significant. And the inhalants have come a long way. How many shares are outstanding now? At one point I had between 2 and 3 percent, but that was when there were less than 50 million shares and the bid was two bits! ... ancient history!

At the time there was such great hope over the needle-free system; from a shareholder's view the management seemed to lack focus. I remember O'shea did a deal with ELAN at one point to develop an insulin meter. The project was discontinued about 18 months later. Had that energy gone into injection development BJCT might have had the Powderject success. The last time I looked at BJCT was over six years ago and at that time I figured the best closure would be for some big Pharma to buy the product line and use it to repackage drugs that had reached their patent life into a new product and an additional term of patent protection. After all, the products had FDA approval and that's a lot of invested work.

Given the de-listing it is going to be difficult to follow BJCT nowadays.

Good luck!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext